CHA Health Systems (CHS) Established in 1960, CHA Health Systems (CHS) has received worldwide recognition and accolades for its excellence in research and clinical translation. It owns and operates, among others: Hollywood Presbyterian Medical Center, one of the largest privately-owned hospitals in Los Angeles with 434 beds and 8 general acute-care hospital facilities throughout Korea with over 2000 beds. CHS continued its international expansion and formed CHAUM, a premier anti-aging center and research centers in the U.S. and Korea. The Company’s activities also include various medical and biotech ventures, including a healthcare investment firm, CHA Bio & Diostech, the leading bio-tech company in the field of stem cell research and treatment development and CMG Pharmaceuticals, both listed on KOSDAQ. In addition, CHS operates a global clinical trial center, the world’s only one-stop clinical trial center for regenerative medicine. In this center, GMP facility, surgery room, recovery room, treatment room, and in-hospitalization facility are centrally located for convenience and quality care. Its customized clinical trial services and state-of-the-art facilities for the development of regenerative medicine are a major supplier to many biotech companies worldwide. With the ultimate vision of becoming a global leader in the next generation of healthcare services, CHS continues to stay at the forefront of medical services by building its global network of hospitals/clinics and research institutes for the advancement of bio-medicine and bio-ventures.